Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Santinami

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Annals of Surgical Oncology|July 14, 2000
Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experienceN Cascinelli, F Belli, M Santinami, et al.
ESMO Open|April 14, 2022
Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter studyM Mandalà, P Rutkowski, F Galli, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcomaF Di Filippo, R Garinei, M Anzà, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2017
Prognostic factors in Merkel cell carcinoma patients undergoing sentinel node biopsyI Mattavelli, R Patuzzo, V Torri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasisC R Rossi, N Mozzillo, A Maurichi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 1999
Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I studyF Di Filippo, C R Rossi, M Vaglini, et al.
In Vivo (Athens, Greece)|May 6, 2009
Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO)F Di Filippo, P Giacomini, C R Rossi, et al.
In Vivo (Athens, Greece)|May 6, 2009
Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusionF Di Filippo, P Giacomini, C R Rossi, et al.
ESMO Open|February 3, 2026
Incidence and risk factors of brain metastases in radically resected melanoma patients: a large international cohort studyM Mandalà, P Rutkowski, R Patuzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2014
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II studyA M Di Giacomo, P A Ascierto, P Queirolo, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Annals of Surgical Oncology|July 14, 2000
Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experienceN Cascinelli, F Belli, M Santinami, et al.
ESMO Open|April 14, 2022
Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter studyM Mandalà, P Rutkowski, F Galli, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcomaF Di Filippo, R Garinei, M Anzà, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2017
Prognostic factors in Merkel cell carcinoma patients undergoing sentinel node biopsyI Mattavelli, R Patuzzo, V Torri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasisC R Rossi, N Mozzillo, A Maurichi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 1999
Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I studyF Di Filippo, C R Rossi, M Vaglini, et al.
In Vivo (Athens, Greece)|May 6, 2009
Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO)F Di Filippo, P Giacomini, C R Rossi, et al.
In Vivo (Athens, Greece)|May 6, 2009
Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusionF Di Filippo, P Giacomini, C R Rossi, et al.
ESMO Open|February 3, 2026
Incidence and risk factors of brain metastases in radically resected melanoma patients: a large international cohort studyM Mandalà, P Rutkowski, R Patuzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2014
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II studyA M Di Giacomo, P A Ascierto, P Queirolo, et al.
Pageof 7